Adarx Pharmaceuticals Inc. , a late-stage developer of gene therapies, raised $446. 3 million in an upsized initial public offering that priced at the top of its marketed range.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-09-24/adarx-pharmaceuticals-raises-446-3-million-in-upsized-us-ipo)